Medspira Announces New Clinical Trial Utilizing Its Innovative mcompass Biofeedback Anorectal Manometry System for Treatment of Fecal IncontinenceJune 26, 2013 9:00 am | by Business Wire | News | Comments
Medspira announces a multi-center randomized clinical trial utilizing an investigational biofeedback device (based on the FDA cleared and currently marketed mcompass Anorectal Manometry system) combined with pelvic floor physical therapy for treatment of fecal incontinence.
Qardio Unveils Daily-Wear, Wireless Devices for Continuous Health Monitoring by Consumers & Their PhysiciansJune 26, 2013 7:00 am | by The Associated Press | News | Comments
Qardio, a healthcare technology company, today unveils two revolutionary, cardiovascular monitoring devices. QardioCore and QardioArm are elegantly designed for effortless daily-wear, continuous monitoring by those with, or at risk of developing, cardiovascular conditions and sharing of data...
New Clinical Study Launches to Evaluate Healing of Knee Cartilage Using a Patient’s Own Regenerative CellsJune 26, 2013 6:00 am | by Business Wire | News | Comments
InGeneron, Inc., an innovator in cell-based technologies for healthcare and veterinary medicine, announced today a study to assess the use of adult adipose derived regenerative cells to enhance cartilage healing after knee surgery. The study will utilize InGeneron’s patented Transpose RT system to prepare regenerative cells from the patient’s own fat tissue.
These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis. A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available.
Novotechnik U.S. has introduced the Vert-X 28HD Series of non-contact angle sensors. These magnetic sensors are designed for harsh environments. They have aluminum housing and are sealed for protection against ingress of liquids and solids to IP 69K.
The new BlueWave LED DX-1000 VisiCure from Dymax is an LED light-curing system which produces visible light energy in a relatively narrow wavelength band centered at 405 nm. This system is designed to provide users with significant advantages over conventional lamp-curing systems...
Schurter is extending its family of Universal Modular Fuses to include a version with 1500 A breaking capacity at rated voltages of 277 VAC/250 VDC. The high breaking capacity of the UMT-H makes this time-lag fuse ideal for applications with high short-circuit currents.
Mill-Max has added 2mm pitch products to their family of shrouded male pin connectors for higher density applications. Like our .100” pitch series, these connectors are effective where a robust, secure connection is demanded, such as frequently mated interconnects and blind mate situations.
When designing a medical device that is meant to be used directly by patients in their home, the designer has to keep in mind that the environment of a patient’s home is likely going to be dramatically different compared to a medical facility.
As balloon catheters are used in critical therapeutic applications, they simply must work as they are intended. Therefore, testing these devices must ensure that failure will not occur. This article looks at the testing process for balloon catheters and what decisions manufacturers need to consider.
In November 2012 and February 2013, Andrew Johnson underwent a surgical procedure, Deep Brain Stimulation surgery, to help control his motor symptoms. This video represents his experience of how DBS has helped him. He is using a device from Medtronic.
Various areas of the brain process our sensory experiences. How the areas of the cerebral cortex communicate with each other and process sensory information has long puzzled neuroscientists. Exploring the sense of touch in mice, brain researchers from the University of Zurich demonstrate that the transmission of sensory information from one cortical area to connected areas depends on the task to solve and the goal-directed behavior.
What if experts could dig into the brain, like archaeologists, and uncover the history of past experiences? This ability might reveal what makes each of us a unique individual, and it could enable the objective diagnosis of a wide range of neuropsychological diseases.
Aethlon Medical, Inc. (OTCQB: AEMD), announced today that the United States Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier@ in the United States. The...
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company has submitted a Premarket Approval (PMA) application to the U.S. Food...